ArticleACS omega2026
Reversible Charge-Mediated Capture and Release of Extracellular Vesicles Using Giant Unilamellar Vesicles.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) play crucial roles in intercellular communication and represent promising therapeutic vehicles, yet current isolation and manipulation methods often irreversibly alter their properties. This study presents a charge-mediated approach for the reversible interaction and release of EVs using Giant Unilamellar Vesicles (GUVs) exploiting tailored surface charges. Negatively charged EVs can be selectively bound through electrostatic interactions with positively charged GUVs, forming stable aggregates. Critically, these interactions are reversible upon the introduction of a negatively charged moiety, oleic acid, which disaggregates the complexes and releases the vesicles. Selective fusion events between oppositely charged GUVs allow modulation of internal composition, while GUVs-EVs interactions remain nonfusogenic. This reversible, charge-based platform offers advantages over current EVs' capture methods, including simplicity, low cost, and the potential for a separation method without permanent labeling.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.